Stage IVB Lung Cancer AJCC v8 Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

DBCOND0111251 (Stage IVB Lung Cancer AJCC v8)Recruiting1 IdentifierTitlePurposeDrugs
NCT02595866Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant NeoplasmsTreatment
NCT03590054A Phase 1b Dose Escalation/Expansion Study of Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesTreatment
NCT04007744Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsTreatment